(19)
(11) EP 4 228 643 A1

(12)

(43) Date of publication:
23.08.2023 Bulletin 2023/34

(21) Application number: 21880683.4

(22) Date of filing: 14.10.2021
(51) International Patent Classification (IPC): 
A61K 31/4706(2006.01)
A61K 31/375(2006.01)
A61K 9/72(2006.01)
A61P 31/14(2006.01)
 A61K 33/18(2006.01)
A61K 33/30(2006.01)
A61P 11/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 33/30; A61P 11/00; A61K 31/4706; A61K 33/18; A61P 31/14; A61K 31/375; A61K 9/0078; A61K 9/006; A61K 9/0043
 
C-Sets:
  1. A61K 31/4706, A61K 2300/00;
  2. A61K 33/18, A61K 2300/00;
  3. A61K 33/30, A61K 2300/00;
  4. A61K 31/375, A61K 2300/00;
(86) International application number:
PCT/SG2021/050621
(87) International publication number:
WO 2022/081093 (21.04.2022 Gazette 2022/16)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 15.10.2020 SG 10202010250W

(71) Applicant: National University Hospital (Singapore) Pte Ltd
Singapore 119228 (SG)

(72) Inventor:
  • SEET, Chee Seong
    Singapore 119228 (SG)

(74) Representative: Forresters IP LLP 
Skygarden Erika-Mann-Straße 11
80636 München
80636 München (DE)

   


(54) COMPOSITION AND METHODS FOR THE PREVENTION AND TREATMENT OF COVID-19 AND RESPIRATORY ILLNESSES